Metabolic factors affecting the mutagenicity of heterocyclic amines

Acrylamide and Other Hazardous Compounds in Heat-Treated Foods

Volumn , Issue , 2006, Pages 358-404

  Glatt, H R ^a  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 66049149135     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-84569-011-3.50016-1     Document Type: Chapter

References (136)

1. Agus C., Ilett K.F., Kadlubar F.F., Minchin R.F. Characterization of an Atp-dependent pathway of activation for the heterocyclic amine carcinogen N-hydroxy-2-amino-3-methylimidazo[4,5-f]quinoline. Carcinogenesis 2000, 21:1213-1219.
2. Alexander J., Wallin H., Holme J.A., Becher G. 4-(2-Amino-1-methyl-imidazo[4,5-b]pyrid-6-yl)phenyl sulfate: a major metabolite of the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the rat. Carcinogenesis 1989, 10:1543-1547.
3. 2-oxidized species of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in rat liver. Carcinogenesis 1991, 12:2239-2245.
4. Alexander J., Fossum B.H., Holme J.A. Metabolism of the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in isolated liver cells from guinea pig, hamster, mouse, and rat. Environ Health Perspect 1994, 102:109-114.
5. Aoyama T., Gelboin H.V., Gonzalez F.J. Mutagenic activation of 2-amino-3-methylimidazo[4,5-f]quinoline by complementary Dna-expressed human liver P450. Cancer Res 1990, 50:2060-2063.
6. Babu S.R., Lakshmi V.M., Huang G.P., Zenser T.V., Davis B.B. Glucuronide conjugates of 4-aminobiphenyl and its A-hydroxy metabolites: pH stability and synthesis by human and dog liver. Biochem Pharmacol 1996, 51:1679-1685.
7. Bashirm Kingston D.G., Carman R.J., Van Tassell R.L., Wilkins T.D. Anaerobic metabolism of 2-amino-3-methyl-3H-imidazo[4,5-f]quinoline (IQ) by human fecal flora. Mutation Res 1987, 190:187-190.
8. Bock K.W. Udp-glucuronosyltransferases 2002, 281-318. Sussex John Wiley & Sons. C. Ioannides (Ed.).
9. Boukouvala S., Fakis G. Arylamine A-acetyltransferases: what we learn from genes and genomes. Drug Metab Rev 2005, 37:511-564.
10. Brown K., Guenther E.A., Dingley K.H., Cosman M., Harvey C.A., Shields S.J., Turteltaub K.W. Synthesis and spectroscopic characterization of site-specific 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine oligodeoxyribo-nucleotide adducts. Aucl Acid Res 2001, 29:1951-1959.
11. Carman R.J., Van Tassell R.L., Kingston D.G., Bashir M., Wilkins T.D. Conversion of IQ, a dietary pyrolysis carcinogen to a direct-acting mutagen by normal intestinal bacteria of humans. Mutation Res 1988, 206:335-342.
12. Cheung C., Ma X., Krausz K.W., Kimura S., Feigenbaum L., Dalton T.P., Nebert D.W., Idle J.R., Gonzalez F.J. Differential metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in mice humanized for Cyp1A1 and Cyp1A2. Chem Res Toxicol 2005, 18:1471-1478.
13. Chou H.-C., Lang N.P., Kadlubar F.F. Metabolic activation of A-hydroxy arylamines and A-hydroxy heterocyclic amines by human sulfotransferase(s). Cancer Res 1995, 55:525-529.
14. Coles B., Nowell S.A., Macleod S.L., Sweeney C., Lang N.P., Kadlubar F.F. The role of human glutathione S-transferases (hGSTs) in the detoxification of the food-derived carcinogen metabolite N-acetoxy-PhIP, and the effect of a polymorphism in hGSTAl on colorectal cancer risk. Mutation Res 2001, 482:3-10.
15. Crofts F.G., Strickland P.T., Hayes C.L., Sutter T.R. Metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) by human cytochrome P4501B1. Carcinogenesis 1997, 18:1793-1798.
16. Crofts F.G., Sutter T.R., Strickland P.T. Metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by human cytochrome P4501A1, P4501A2 and P4501B1. Carcinogenesis 1998, 19:1969-1973.
17. Dashwood R.H. Use of transgenic and mutant animal models in the study of heterocyclic amine-induced mutagenesis and carcinogenesis. JBiochem Mol Biol 2003, 36:35-42.
18. Davis C.D., SchutH A.J., Snyderwine E.G. Enzymatic phase-II activation of the N-hydroxylamines of IQ, MeIQx and PhIP by various organs ofmonkeys and rats. Carcinogenesis 1993, 14:2091-2096.
19. Dirr A., Wild D. Synthesis and mutagenic activity of nitro-imidazoarenes: a study on the mechanism of the genotoxicity of heterocyclic arylamines and nitroarenes. Mutagenesis 1988, 3:147-152.
20. Espinosa-Aguirre J.J., Yamada M., Matsui K., Watanabe M., Sofuni T., Nohmi T. New O-acetyltransferase-deficient Ames Salmonella strains generated by specific gene disruption. Mutation Res 1999, 439:159-169.
21. Felton J.S., Knize M.G., Shen N.H., Lewis P.R., Andresen B.D., Happe J., Hatch F.T. 'The isolation and identification of a new mutagen from fried ground beef: 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)'. Carcinogenesis 1986, 7:1081-1086.
22. Frandsen H., Alexander J. N-Acetyltransferase-dependent activation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine: formation of2-amino-1-methyl-6-(5-hydroxy)phenylimidazo [4,5-b]pyridine, a possible biomarker for the reactive dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Carcino-genesis 2000, 21:1197-1203.
23. Frederiksen H., Frandsen H. In vitro metabolism of two heterocyclic amines, 2-amino-9H-pyrido[2,3-b]indole (AαC) and 2-amino-3-methyl-9H-pyrido[2,3-b]indole (MeAαC) in human and rat hepatic microsomes. Pharmacol Toxicol 2002, 90:127-134.
24. Frederiksen H., Frandsen H. Impact of five cytochrome P450 enzymes on the metabolism of two heterocyclic aromatic amines, 2-amino-9H-pyrido[2,3-b]indole (AαC) and 2-amino-3-methyl-9H-pyrido[2,3-b]indole(MeAαC). Pharmacol Toxicol 2003, 92:246-248.
25. Frederiksen H., Frandsen H. Excretion of metabolites in urine and faeces from rats dosed with the heterocyclic amine, 2-amino-9H-pyrido[2,3-b]indole (AαC). Food Chem Toxicol 2004, 42:879-885.
26. Fuscoe J.C., Wu R., Shen N.H., Healy S.K., Felton J.S. Base-change analysis of revertants of the hisD3052 allele in Salmonella typhimurium. Mutation Res 1988, 201:241-251.
27. Gemzik B., Greenway D., Nevins C., Parkinson A,. Regulation of two electro-phoretically distinct proteins recognized by antibody against rat liver cytochrome P4503A1. JBiochem Toxicol 1992, 7:43-52.
28. Girard H., Thibaudeau J., Court M.H., Fortier L.C., Villeneuve L., Caron P., Hao Q., Von Moltke L.L., Greenblatt D.J., Guillemette C. UGT1A1 polymorphisms are important determinants of dietary carcinogen detoxification in the liver. Hepatology 2005, 42:448-457.
29. Glatt H.R. Sulfotransferases in the bioactivation of xenobiotics. Chem-Biol Interact 2000, 129:141-170.
30. Glatt H.R. Sulphotransferases. Handbook of Enzyme Systems that Metabolise Drugs and Other Xenobiotics 2002, 353-439. Sussex, John Wiley & Sons. C. Ioannides (Ed.).
31. Glatt H.R. 'Activation and inactivation of carcinogens by human sulfo-transferases', in Pacifici G M and Coughtrie M W H 2005, 281-306. Human Sulphotransferases, London, Taylor & Francis.
32. Glatt H.R., Meinl W. Pharmacogenetics of soluble sulfotransferases (sults. Naunyn-schmiedeberg's arch pharmacol 2004, 369:55-68.
33. Glatt H.R., Meinl W. Sulfotransferases and acetyltransferases in mutagenicity testing: technical aspects. Meth enzymol 2005, 400:230-249.
34. Glatt H.R., Pabel U., Meinl W., Frederiksen H., Frandsen H., Muckel E,. 'Bioactivation of the heterocyclic aromatic amine 2-amino-3-methyl-9H-pyrido [2,3-b]indole (MeAαC) in recombinant test systems expressing human xenobiotic-metabolizing enzymes'. Carcinogenesis 2004, 25:801-807.
35. Gorlewska-Roberts K.M., Teitel C.H., Lay J.O., Roberts D.W., Kadlubar F.F,. Lactoperoxidase-catalyzed activation of carcinogenic aromatic and heterocyclic amines. Chem-Res Toxicol 2004, 17:1659-1666.
36. Guengerich F.P., Dannan G.A., Wright S.T., Martin M.V., Kaminsky L.S. 'Purification and characterization of liver microsomal cytochromes P450: electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or (β -naphthoflavone'. Biochemistry 1982, 21:6019-6030.
37. Hasmmons G.J., Milton D., Stepps K., Guengerich F.P., Tukey R.H., Kadlubar F.F. Metabolism of carcinogenic heterocyclic and aromatic amines by recombinant human cytochrome P450 enzymes. Carcinogenesis 1997, 8:851-854.
38. Hashimoto Y., Shudo K., Okamoto T. 'Activation of a mutagen, 3-amino-1-methyl-5H-pyrido[4,3-b]indole: identification of 3-hydroxyamino-1-methyl-5H-pyrido[4,3-b]indole and its reaction with Dna'. Biochem Biophys Res Commun 1980, 96:355-362.
39. Heflich R.H., Neft R.E. Genetic toxicity of 2-acetylaminofluorene, 2-amino fluorene and some of their metabolites and model metabolites. Mutation Res 1994, 318:73-174.
40. Hein D.W., Rustan T.D., Ferguson R.J., Doll M.A., Gray K. Metabolic activation of aromatic and heterocyclic N-hydroxyarylamines by wild-type and mutant recombinant human NAT1 and NAT2 acetyltransferases. Arch Toxicol 1994, 68:129133.
41. Hollnagel H., Glatt H.R. Bioaktivierung heterozyklischer aromatischer Amine in toxikologischen Modellsystemen - Beurteilung des kanzerogenen Potentials. Potentiell kanzerogene Inhaltsstoffe in Lebensmitteln: Beiträge zum dritten Workshop der Arbeitsgruppe Lebensmittelqualität und - sicherheit 2003, 42-51. Agrar- und Ernährungswissenschaftliche Fakultät der Christian-Albrechts-Universität Kiel. M. Huhn (Ed.).
42. Imaoka S., Yoneda Y., Matsuda T., Degawa M., Fukushima S., Funae Y. Mutagenic activation of urinary bladder carcinogens by CYP4B1 and the presence of CYP4B1 in bladder mucosa. Biochem Pharmacol 1997, 54:677-683.
43. Ishii K., Yamazoe Y., Kamataki T., Kato R. Metabolic activation of glutamic acid pyrolysis products, 2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole and 2-amino-dipyrido[1,2-a:3',2'-d]imidazole, by purified cytochrome P450'. Chem-Biol Interact 1981, 38:1-13.
44. Iwata H., Yoshimi N., Mori Y., Hara A., Mori H. Genotoxicity of heterocyclic amines in the hepatocyte/Dna repair assay using hepatocytes of rats or mice pretreated with 3-methylcholanthrene. Mutation Res 1990, 244:1-6.
45. Josephy P.D., Batty S.M., Boverhof D.R. Recombinant human P450 forms 1A1, 1A2, and 1B1 catalyze the bioactivation of heterocyclic amine mutagens in Escherichia coli lacZ strains. Environ Mol Mutagen 2001, 38:12-18.
46. Kaderlik K.R., Minchin R.F., Mulder G.J., Ilett K.F., Daugaard-Jenson M., Teitel C.H., Kadlubar F.F. Metabolic activation pathway for the formation of Dna adducts of the carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in rat extrahepatic tissues. Carcinogenesis 1994, 15:1703-1709.
47. Kaderlik K.R., Mulder G.J., Shaddock J.G., Casciano D.A., Teitel C.H., Kadlubar F.F. Effect of glutathione depletion and inhibition of glucuronidation and sulfation on 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP) metabolism, PhIP-Dna adduct formation and unscheduled Dna synthesis in primary rat hepatocytes. Carcinogenesis 1994, 15:1711-1716.
48. Kaderlik K.R., Mulder G.J., Turesky R.J., Lang N.P., Teitel C.H., Chiarelli M.P., Kadlubar F.F. Glucuronidation of A-hydroxy heterocyclic amines by human and rat liver microsomes. Carcinogenesis 1994, 15:1695-1701.
49. Kanai Y., Manabe S., Wada O. In vitro and in vivo N-acetylation of carcinogenic glutamic acid pyrolysis products in humans. Carcinogenesis 1988, 9:2179-2184.
50. Kanazawa K., Ashida H., Danno G. Comparison in metabolic activity of cytochrome P450 1A1 on heterocyclic amines between human and rat. JAgr Food Chem 1999, 47:4956-4961.
51. Kassie F., Rabot S., Kundi M., Chabicovsky M., Qin H.M., Knasmuller S. Intestinal microflora plays a crucial role in the genotoxicity of the cooked food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline (IQ). Carcinogenesis 2001, 22:1721-1725.
52. Kato R., Yamazoe Y. Metabolic activation and covalent binding to nucleic acids of carcinogenic heterocyclic amines from cooked foods and amino acid pyrolysates. Jpn J Cancer Res 1987, 78:297-311.
53. Kato R., Kamataki T., Yamazoe Y. N-Hydroxylation of carcinogenic and mutagenic aromatic amines. Environ Health Perspect 1983, 49:21-25.
54. Kimura S., Kawabe M., Yu A.M., Morishima H., Fernandez-Salguero P., Hammons G.J., Ward J.M., Kadlubar F.F., Gonzalez F.J. Carcinogenesis of the food mutagen PhIP in mice is independent of CYP1A2. Carcinogenesis 2003, 24:583-587.
55. King R.S., Teitel C.H., Shaddock J.G., Casciano D.A., Kadlubar F.F. Detoxification of carcinogenic aromatic and heterocyclic amines by enzymatic reduction of the A-hydroxy derivative. Cancer Lett 1999, 143:167-171.
56. King R.S., Teitel C.H., Kadlubar F.F. In vitro bioactivation of A-hydroxy-2-amino-a-carboline. Carcinogenesis 2000, 21:1347-1354.
57. Kosuge T., Tsuji K., Wakabayashi K., Okamoto T., Shudo K., Iitaka Y., Itai A., Sugimura T., Kawachit Nagao M., Yahagit T., Seino Y. Isolation and structure studies of mutagenic principles in amino acid pyrolysates. Chem Pharm Bull (Tokyo) 1978, 26:611-619.
58. Kulp K.S., Knize M.G., Malfattim A., Salmon C.P., Felton J.S. Identification of urine metabolites of 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine following consumption of a single cooked chicken meal in humans. Carcinogenesis 2000, 21:2065-2072.
59. Landsiedel R., Engst W., Scholtyssek M., Seidel A., Glatt H.R. Benzylic sulphuric acid esters react with diverse functional groups and often form secondary reactive species. Polycyclic Aromat Compds 1996, 11:341-348.
60. 14c]2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Cancer Lett 1999, 143:135-138.
61. Langouet S., Welti D.H., Kerriguy N., Fay L.B., Huynh-Ba T., Markovic J., Guengerich F.P., Guillouzo A., Turesky R.J. 'Metabolism of 2-amino-3,8-dimethyl-imidazo[4,5-f]quinoxaline in human hepatocytes: 2-amino-3-methylimidazo[4,5-f]quinoxaline-8-carboxylic acid is a major detoxication pathway catalyzed by cytochrome P450 1A2'. Chem Res Toxicol 2001, 14:211-221.
62. Langouet S., Paehler A., Welti D.H., Kerriguy N., Guillouzo A., Turesky R.J. Differential metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in rat and human hepatocytes. Carcinogenesis 2002, 23:115-122.
63. Leff M.A., Epstein P.N., Doll M.A., Fretland A.J., Devanaboyina U.S., Rustan T.D., Hein D.W. Prostate-specific human N-acetyltransferase 2 (Nat2) expression in the mouse. J Pharmacol Exp Ther 1999, 290:182-187.
64. Lewis A.J., Walle U.K., King R.S., Kadlubar F.F., Falany C.N., Walle T. Bioactivation of the cooked food mutagen A-hydroxy-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by estrogen sulfotransferase in cultured human mammary epithelial cells. Carcinogenesis 1998, 19:2049-2053.
65. Lin D.X., Meyer D.J., Ketterer B., Lang N.P., Kadlubar F.F. Effects of human and rat glutathione S-transferases on the covalent Dna binding of the N-acetoxy derivatives of heterocyclic amine carcinogens in vitro:apossible mechanism of organ specificity in their carcinogenesis. Cancer Res 1994, 54:4920-4926.
66. Lin D.X., Lang N.P., Kadlubarf F. Species differences in the biotransformation of the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by hepatic microsomes and cytosols from humans, rats, and mice. Drug Metab Dispos 1995, 23:518-524.
67. Malfatti M.A., Felton J.S. A-Glucuronidation of 2-amino-1-methyl-6-phenylimidazo[4,5-f]pyridine (PhIP) and N-hydroxy-PhIP by specific human Udp-glucuronosyltransferases. Carcinogenesis 2001, 22:1087-1093.
68. Malfatti M.A., Felton J.S. Human Udp-glucuronosyltransferase 1A1 is the primary enzyme responsible for the N-glucuronidation of N-hydroxy-PhIP in vitro. Chem Res Toxicol 2004, 17:1137-1144.
69. 14c]2 -amino-1-methyl-6-phenylimidazo[4,5-b]pyridine metabolites in humans. Carcinogenesis 1999, 20:705-713.
70. Malfatti M.A., Wu R.W., Felton J.S. The effect of Udp-glucuronosyltransferase 1a1 expression on the mutagenicity and metabolism of the cooked-food carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in Cho cells. Mutation Res 2005, 570:205-214.
71. Maron D.M., Ames B.N. Revised methods for the Salmonella mutagenicity test',Mutation. Res 1983, 113:73-215.
72. 6 to the mutagenic action of nitroarenes. Mutation Res 1983, 121:17-23.
73. Mcmanus M.E., Burgess W.M., Veronese M.E., Huggett A., Quattrochil C., Tukey R.H. Metabolism of 2-acetylaminofluorene and benzo[a]pyrene and activation of food-derived heterocyclic amine mutagens by human cytochromes P450. Cancer Res 1990, 50:3367-3376.
74. Meijer J., Depierre J.W., Rannug U. Measurement of drug-metabolizing systems in Salmonella typhimurium strains G46, TA15135, TA100, TA1538 and TA98. Chem-Biol Interact 1980, 31:247-254.
75. Meinl W., Meerman J.H., Glatt H.R. Differential activation of promutagens by alloenzymes of human sulfotransferase 1A2 expressed in Salmonella typhimurium. Pharmacogenetics 2002, 12:677-689.
76. Meinl W., Pabel U., Osterloh-Quiroz M., Hengstler J.G., Glatt H.R. Human sulfotransferases are involved in the activation of aristolochic acids and are expressed in renal target tissue. Int J Cancer 2006, 118:1090-1097.
77. Minchin R.F., Reeves P.T., Teitel C.H., Mcmanus M.E., Mojarrabi B., Ilett K.F., Kadlubar F.F. N-and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferases expressed in Cos-1 cells. Biochem Biophys Res Commun 1992, 185:839-844.
78. Muckel E., Frandsen H., Glatt H.R. Heterologous expression of human A-acetyltransferases 1 and 2 and sulfotransferase 1A1 in Salmonella typhimurium for mutagenicity testing of heterocyclic amines. Food Chem Toxicol 2002, 40:1063-1068.
79. Mulder G.J., Hinson J.A., Nelson W.L., Thorgeirsson S.N. Role of sulfo-transferase from rat liver in the mutagenicity of N-hydroxy-2-acetylaminofluorene in Salmonella typhimurium. Biochem Pharmacol 1977, 26:1356-1358.
80. Nagao M., Honda M., Seino Y., Yahagit T., Sugimura T. Mutagenicities of smoke condensates and the charred surface of fish and meat. Cancer Lett 1977, 2:221-226.
81. Nagao M., Takahashi Y., Yahagi T., Sugimura T., Takeda K., Shudo K., Okamoto T. Mutagenicities of Υ-carboline derivatives related to potent mutagens found in tryptophan pyrolysates. Carcinogenesis 1980, 1:451-454.
82. Negishic Umemoto A., Rafter J.J., Sato S., Sugimura T. N-Acetyl derivative as the major active metabolite of 2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole in rat bile'. Mutation Res 1986, 175:23-28.
83. Niwa T., Yamazoe Y., Kato R. ''Metabolic activation of 2-amino-9H-pyrido[2,3-b]indole by rat-liver microsomes'. Mutation Res 1982, 95:159-170.
84. Nowell S.A., Massengill J.S., Williams S., Radominska-Pandya A., Tephly T.R., Cheng Z.Q., Strassburg C.P., Tukey R.H., Macleod S.L., Lang N.P., Kadlubar F.F. Glucuronidation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine by human microsomal Udp-glucuronosyltransferases: identification of specific Ugt1a family isoforms involved. Carcinogenesis 1999, 20:1107-1114.
85. Oda Y., Yamazakih H., Shimada T. Role of human N-acetyltransferases, NAT1 or NAT2, in genotoxicity of nitroarenes and aromatic amines in Salmonella typhimurium Nm6001 andNM6002. Carcinogenesis 1999, 20:1079-1083.
86. Oda Y., Aryal P., Terashita T., Gillam E.M.J., Guengerich F.P., Shimada T. 'Metabolic activation of heterocyclic amines and other procarcinogens in Salmonella typhimurium umu tester strains expressing human cytochrome P4501A1, 1A2, 1B1, 2C9, 2D6, 2E1, and 3A4 and human Nadph-P450 reductase and bacterial O-acetyltransferase'. Mutation Res 2001, 492:81-90.
87. Ozawa S., Chou H.-C., Kadlubar F.F., Nagata K., Yamazoe Y., Kato R. Activation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine by cDNA-expressed human and rat arylsulfotransferases. Jpn J Cancer Res 1994, 85:1220-1228.
88. Raftogianis R.B., Wood T.C., Otterness D.M., Van Loon J.A., Weinshilboum R.M. Phenol sulfotransferase pharmacogenetics in humans: association of common Sult1a1 alleles with Ts Pst phenotype. Biochem Biophys Res Commun 1997, 239.
89. Raza H., King R.S., Squires R.B., Guengerich F.P., Miller D.W., Freeman J.P., Lang N.P., Kadlubar F.F. Metabolism of 2-amino-α-carboline: a food-borne hetero-cyclic amine mutagen and carcinogen by human and rodent liver microsomes and by human cytochrome P4501A2. Drug Metab Dispos 1996, 24:395-400.
90. Rosenkranz H.S., Mermelstein R. Mutagenicity and genotoxicity of nitro-arenes: all nitro-containing chemicals were not created equal. Mutation Res 1983, 114:217-267.
91. Saito K., Kator R. 'Glutathione conjugation of arylnitroso compound: detection and monitoring labile intermediates in situ inside a fast atom bombardment mass spectrometer'. Biochem Biophys Res Commun 1984, 124:1-5.
92. Saito K., Yamazoe Y., Kamatakit K., Kato R. Activation and detoxication of A-hydroxy-Trp-P-2 by glutathione and glutathione transferases. Carcinogenesis 1983, 4:1551-1557.
93. Saito K., Yamazoe Y., Kamataki T., Kato R. 'Syntheses of hydroxyamino, nitroso and nitro derivatives of Trp-P-2 and Glu-P-1, amino acid pyrolysate mutagens, and their direct mutagenicities towards Salmonella typhimurium TA98 and TA98NR'. Carcinogenesis 1983, 4:1547-1550.
94. Saito K., Yamazoe Y., Kamataki T., Kato R. Glutathione transferase-mediated and non-enzymatic activation and detoxication of the A-hydroxy derivative of Trp-P-2, a potent pyrolysate promutagen. Xenobiotica 1984, 14:545-548.
95. Saito K., Shinohara A., Kamataki T., Kato R. Metabolic activation of mutagenic N-hydroxyarylamines by O-acetyltransferase in Salmonella typhimurium Ta98. Arch Biochem Biophys 1985, 239:286-295.
96. Saito K., Shinohara A., Kamataki T., Kato R. A new assay for A-hydroxy-arylamine O-acetyltransferase: reduction of N-hydroxyarylamines through N-acetoxyarylamines. Anal Biochem 1986, 152:226-231.
97. Sengstag C., Eugsterh P., Wurgler F.E. High promutagen activating capacity of yeast microsomes containing human cytochrome P450 1A and human Nadph-cytochrome P450 reductase. Carcinogenesis 1994, 15:837-843.
98. Sheratt P.J., Hayes J.D. Glutathione S-transferases 2002, 317-352. Sussex, John Wiley & Sons. C. Ioannides (Ed.).
99. Shimada T., Hayes C.L., Yamazaki H., Amin S., Hecht S.S., Guengerich F.P., Sutter T.R. Activation of chemically diverse procarcinogens by human cytochrome P450 1B1. Cancer Res 1996, 56:2979-2984.
100. Shinohara A., Yamazoe Y., Saito K., Kamataki T., Kato R. Species differences in the N-acetylation by liver cytosol of mutagenic heterocyclic aromatic amines in protein pyrolysates. Carcinogenesis 1984, 5:683-686.
101. Shinohara A., Saito K., Yamazoe Y., Kamataki T., Kato R. Acetyl coenzyme A dependent activation of N-hydroxy derivatives of carcinogenic arylamines: mechanism of activation, species difference, tissue distribution, and acetyl donor specificity. Cancer Res 1986, 46:4362-4367.
102. Smith B.A., Springfield J.R., Gutmann H.R. Interaction of the synthetic ultimate carcinogens, N-sulfonoxy- and N-acetoxy-2-acetylaminofluorene, and of enzymatically activated N-hydroxy-2-acetylaminofluorene with nucleophiles. Carcinogenesis 1986, 7:405-411.
103. Snyderwine E.G., Yu M.C., Schut H.A., Knigth-Jones J., Kimura S. Effect of Cyp1a2 deficiency on heterocyclic amine Dna adduct levels in mice. Food Chem Toxico 2002, 40:1529-1533.
104. Stillwell W.G., Turesky R.J., Sinha R., Skipper P.L., Tannenbaum S.R. Biomonitoring of heterocyclic aromatic amine metabolites in human urine. Cancer Lett 1999, 143:145-148.
105. Strassburg C.P., Manns M.P., Tukey R.H. Expression of the Udp-glucuronosyltransferase 1a locus in human colon: identification and characterization of the novel extrahepatic UGT1A8. J Biol Chem 1998, 273:719-8726.
106. Styczynski P.B., Blackmon R.C., Groopman J.D., Kensler T.W. The direct glucuronidation of 2-amino-1-methyl-6-phenylimidazo[4,5-f] pyridine (PhIP) by human and rabbit liver microsomes. Chem Res Toxicol 1993, 846-851.
107. Sugamori K.S., Wong S., Gaedigk A., Yu V., Abramovici H., Rozmahel R., Grant D.M. Generation and functional characterization of arylamine N-acetyl-transferase Nat1/Nat2 double-knockout mice. Mol Pharmacol 2003, 64:170-179.
108. Sugimura T., Kawachi T., Nagao M., Yahagi T., Seino Y., Okamoto T., Shudo K., Kosuge T., Tsuji K., Wakabayashi K., Iitaka Y., Itai A. Mutagenic principle(s) in tryptophan and phenylalanine pyrolysis products. Proc Jap Acad 1977, 53:58-61.
109. Sugimura T., Wakabayashi K., Nakagama H., Nagao M. Heterocyclic amines: mutagens/carcinogens produced during cooking of meat and fish. Cancer Sci 2004, 95:290-299.
110. Takayama K., Yamashita K., Wakabayashi K., Sugimura T., Nagao M. DNA modification by 2-amino-1-methyl-6-phenylimidazo[4,5-f]pyridine in rats. Jpn J Cancer Res 1989, 80:1145-1148.
111. Turesky R.J. Interspecies metabolism of heterocyclic aromatic amines and the uncertainties in extrapolation of animal toxicity data for human risk assessment. Mol Autr Food Res 2005, 49:101-117.
112. Turesky R.J., Skipper P.L., Tannenbaum S.R., Coles B., Ketterer B. Sulfamate formation is a major route for detoxification of 2-amino-3-methylimidazo[4,5- f]quinoline in the rat. Carcinogenesis 1986, 7:1483-1485.
113. Turesky R.J., Lang N.P., Butler M.A., Teitel C.H., Kadlubar F.F. Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. Carcinogenesis 1991, 12:1839-1845.
114. Turesky R.J., Constable A., Richoz J., Varga N., Markovic J., Martin M.V., Guengerich F.P. Activation of heterocyclic aromatic amines by rat and human liver microsomes and by purified rat and human cytochrome P450 1A2. Chem Res Toxicol 1998, 11:925-936.
115. 8- andN-oxidation of 2-amino-3,8- dimethylimidazo[4,5-f]quinoxaline by human and rat liver microsomes and cytochromes P450 1A2. Chem Res Toxicol 2001, 14:901-911.
116. Turteltaub K.W., Dingley K.H., Curtis K.D., Malfatti M.A., Turesky R.J., Garner R.C., Felton J.S., Lang N.P. 'Macromolecular adduct formation and metabolism of heterocyclic amines in humans and rodents at low doses'. Cancer Lett 1999, 143:149-155.
117. Wakabayashi K., Nagao M., Esumi H., Sugimura T. Food-derived mutagens and carcinogens. Cancer Res 1992, 52:2092s-2098s.
118. Wakabayashi K., Kim I.S., Kurosaka R., Yamaizumi Z., Ushiyama H., Takahashi M., Koyota S., Tada A., Nukaya H., Goto S., Sugimura T., Nagao M. Identification of new mutagenic heterocyclic amines and quantification of known heterocyclic amines 1995, 39-49. Princeton, Princeton Scientific Publishing Co., Princess Takamatsu symposium.
119. Wallin H., Mikalsen A., Guengerich F.P., Ingelman-Sundberg M., Solberg K.E., Rossland O.J., Alexander J. Differential rates of metabolic activation and detoxication of the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by different cytochrome P450 enzymes. Carcinogenesis 1990, 11:489-492.
120. Wang S.L., He X.Y., Hong J.Y. Human cytochrome P450 2S1: lack of activity in the metabolic activation of several cigarette smoke carcinogens and in the metabolism of nicotine. Drug Metab Dispos 2005, 33:336-340.
121. Watanabe M., Ishidate M., Nohmi T. Sensitive method for the detection of mutagenic nitroarenes and aromatic amines: new derivatives of Salmonella typhimurium tester strains possessing elevated O-acetyltransferase levels. Mutation Res 1990, 234:337-348.
122. Weisburger J.H., Rivenson A., Reinhardt J., Aliaga C., Braley J., Dolan L.M., Williams G.M., Zang E., Kingston D.G., Bashirm M. Genotoxicity and carcinogenicity in rats and mice of 2-amino-3,6-dihydro-3-methyl-7H-imidazolo[4,5-f]quinolin-7-one: an intestinal bacterial metabolite of 2-amino-3-methyl-3H-imidazo[4,5-f]quinoline. J Aatl Cancer Inst 1994, 86:25-30.
123. Wiese F.W., Thompson P.A., Kadlubar F.F. Carcinogen substrate specificity of human COX-1 and COX-2. Carcinogenesis 2001, 22:5-10.
124. Wild D., Degen G.H. Prostaglandin H synthase-dependent mutagenic activation of heterocyclic aromatic amines of the IQ-type. Carcinogenesis 1987, 8:541-545.
125. Wild D., Watkins B.E., Vanderlaan M. Azido-PhIP and nitro-PhIP, relatives of the heterocyclic arylamine and foodmutagen PhIP: mechanism of their mutagenicity in Salmonella. Carcinogenesis 1991, 12:1091-1096.
126. Wild D., Feser W., Michel S., Lord H.L., Josephy P.D. Metabolic activation of heterocyclic aromatic amines catalyzed by human arylamine N-acetyltransferase isozymes (NAT1 and NAT2) expressed in Salmonella typhimurium. Carcinogenesis 1995, 16:643-648.
127. Williams J.A., Stone E.M., Millar B.C., Hewer A., Phillips D.H. Pathways of heterocyclic amine activation in the breast: DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) formed by peroxidases and in human mammary epithelial cells and fibroblasts. Mutagenesis 2000, 15:149-154.
128. Wölfel C., Heinrich-Hirsch B., Schulz-Schalge T., Seidel A., Frank H., Ramp U., WäCHTER F., Wiebel F.J., Gonzalez F., Greim H., Doehmer J. 'Genetically engineered V79 Chinese hamster cells for stable expression of human cytochrome P450IA2'. Eur J Pharmacol 1992, 228:95-102.
129. Wolz E., Pfau W., Degen G.H. Bioactivation of the food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) by prostaglandin-H synthase and by monooxygenases: Dna adduct analysis. Food Chem Toxicol 2000, 38:513-522.
130. Yamada M., Mori M., Sugimura T. 'Myeloperoxidase-catalyzed binding of 3-amino-1-methyl-5H-pyrido[4,3-b]indole, a tryptophan pyrolysis product, to protein'. Chem-Biol Interact 1980, 33:19-33.
131. Yamashita K., Adachim Kato S., Nakagama H., Ochiaim Wakabayashi K., Sato S., Nagao M., Sugimura T. DNA adducts formed by 2-amino-3,8-dimethyl-imidazo[4,5-f]quinoxaline in rat liver: dose-response on chronic administration. Jpn J Cancer Res 1990, 81:470-476.
132. Yamazakiy Fujita K., Nakayama K., Suzuki A., Nakamura K., Yamazaki H., Kamataki T. 'Establishment of ten strains of genetically engineered Salmonella typhimurium TA1538 each co-expressing a form of human cytochrome P450 with Nadph-cytochrome P450 reductase sensitive to various promutagens'. Mutation Res 2004, 562:151-162.
133. Yamazoe Y., Ishii K., Kamataki T., Kato R., Sugimura T. Isolation and characterization of active metabolites of tryptophan-pyrolysate mutagen, Trp-P-2, formed by rat liver microsomes. Chem-Biol Interact 1980, 30:125-138.
134. Yamazoe Y., Tada M., Kamataki T., Kato R. Enhancement of binding of A-hydroxy-Trp-P-2 to DNA by seryl-tRNA synthetase. Biochem Biophys Res Commun 1981, 102:432-439.
135. Yamazoe Y., Shimada M., Shinohara A., Saito K., Kamataki T., Kato R. Catalysis of the covalent binding of 3-hydroxyamino-1-methyl-5H-pyrido[4,3-b]indole to DNA by a L-proline- and adenosine triphosphate-dependent enzyme in rat hepatic cytosol. Cancer Res 1985, 45:2495-2500.
136. Yanagawa H., Sawada M., Deguchi T., Gonzalez F.J., Kamataki T. Stable expression of human CYP1A2 and N-acetyltransferases in Chinese hamster CHL cells: mutagenic activation of 2-amino-3-methylimidazo[4,5-f]quinoline and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline. Cancer Res 1994, 54:3422-3427.